Literature DB >> 16144667

Prostate cancer screening between low-income African-American and Caucasian men.

Jay H Fowke1, David Schlundt, Lisa B Signorello, Flora A M Ukoli, William J Blot.   

Abstract

OBJECTIVE: African-Americans (AA) are more likely than Caucasians (CA) to be diagnosed with advanced prostate cancer, perhaps due to delayed detection. We investigated racial differences in prostate cancer screening according to age and socioeconomic and demographic indices in a large and predominantly low-income population.
METHODS: In-person interviews were conducted with 12,552 men, 84% AA, recruited during 2002 through 2004 from 25 community health centers in the southern United States. Prostate specific antigen test (PSA) and digital rectal examination (DRE) histories, and socioeconomic and demographic indices (i.e., education, household income, health insurance, and marital status) were determined. Odds ratios (OR) from logistic regression summarized the screening and race association as a function of age, while controlling for socioeconomic status (SES).
RESULTS: Racial differences in screening prevalence varied with age. Of men older than 65 years, CA were significantly more likely to report a PSA test (OR = 1.4) or DRE (OR = 1.5) within the past 12 months. However, these disparities were reduced with control for SES (PSA: OR =1.2; DRE: OR = 1.3, P > 0.05). In contrast, at ages younger than 65, CA were equally or less likely to have received a recent PSA test or DRE, particularly at ages 45-49 years (PSA: OR = 0.7; DRE: OR = 0.9), with little change after SES adjustment.
CONCLUSIONS: Consistent with several screening recommendations, younger AA men, especially those younger than age 50, are more likely than CA to have had a recent PSA test or DRE, independent of SES. Of men older than age 65, less frequent use of screening among AA than CA seems partly attributable to SES and factors other than race.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16144667     DOI: 10.1016/j.urolonc.2005.01.002

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  12 in total

1.  Race and socioeconomic status are independently associated with benign prostatic hyperplasia.

Authors:  Jay H Fowke; Harvey J Murff; Lisa B Signorello; Lars Lund; William J Blot
Journal:  J Urol       Date:  2008-09-18       Impact factor: 7.450

2.  Risk factors for metastatic prostate cancer: A sentinel event case series.

Authors:  Channing J Paller; Alexander P Cole; Alan W Partin; Michael A Carducci; Norma F Kanarek
Journal:  Prostate       Date:  2017-08-08       Impact factor: 4.104

3.  The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study.

Authors:  K A Moses; Z Zhao; Y Bi; J Acquaye; A Holmes; W J Blot; J H Fowke
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-07-11       Impact factor: 5.554

4.  Limited PSA testing in indigent men in South Texas: an appropriate care or missing a prevention opportunity?

Authors:  Yuanyuan Liang; Fei Du; Ian M Thompson; Barbara J Turner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-07-20       Impact factor: 4.254

5.  Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population.

Authors:  G M Monawar Hosain; Maureen Sanderson; Xianglin L Du; Wenyaw Chan; Sara S Strom
Journal:  Cent Eur J Public Health       Date:  2011-03       Impact factor: 1.163

6.  Race and the likelihood of localized prostate cancer at diagnosis among men in 4 southeastern states.

Authors:  Mohammed Norman Oliver; George J Stukenborg
Journal:  J Natl Med Assoc       Date:  2009-08       Impact factor: 1.798

7.  Diabetes and prostate cancer screening in black and white men.

Authors:  Maureen Sanderson; Jay H Fowke; Loren Lipworth; Xijing Han; Flora Ukoli; Ann L Coker; William J Blot; Margaret K Hargreaves
Journal:  Cancer Causes Control       Date:  2013-07-17       Impact factor: 2.506

8.  Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach.

Authors:  Shannon M Lynch; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-05       Impact factor: 4.254

9.  A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France.

Authors:  Amine Benchikh; Caroline Savage; Angel Cronin; Gilles Salama; Arnauld Villers; Hans Lilja; Andrew Vickers
Journal:  BMC Cancer       Date:  2010-11-22       Impact factor: 4.430

10.  Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.

Authors:  Kevin H Kensler; Claire H Pernar; Brandon A Mahal; Paul L Nguyen; Quoc-Dien Trinh; Adam S Kibel; Timothy R Rebbeck
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.